|
Market Closed -
Other stock markets
|
After market 07:42:27 pm | |||
| 2.88 USD | -8.57% |
|
2.92 | +1.39% |
NovaBay Pharmaceuticals, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 14.73 million compared to USD 14.4 million a year ago. Net loss was USD 9.64 million compared to USD 10.61 million a year ago.
Basic loss per share from continuing operations was USD 138.6 compared to USD 353.5 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -59.66% | 3.32M | |
| +46.19% | 55.7B | |
| -6.14% | 39.57B | |
| +39.53% | 39.91B | |
| -6.65% | 28.16B | |
| +12.33% | 26.3B | |
| -21.78% | 18.94B | |
| -0.35% | 12.12B | |
| +24.18% | 12.12B | |
| +28.38% | 12.17B |
NOVABAY PHARMACEUTICALS, INC. 
